Evidence map›Paper›PMID 24214983›Full record

ArticleThe Journal of biological chemistry2014

A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.

Sebastian Temme, Martin Zacharias, Jürgen Neumann, Sebastian Wohlfromm, Angelika König, Nadine Temme, Sebastian Springer, John Trowsdale, Norbert Koch

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. HLA-DPNature communications · 2017
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Non-Neanderthal origin of the HLA-DPB1*0401.The Journal of biological chemistry · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sebastian TemmeFrom the Section of Immunobiology, Institute of Genetics, University of Bonn, 53115 Bonn, Germany.
Martin Zacharias
Jürgen Neumann
Sebastian Wohlfromm
Angelika König
Nadine Temme
Sebastian Springer
John Trowsdale
Norbert Koch

Funding

Medical Research Council G0901682Wellcome Trust 100140
6 · The paper itself

Abstract

HLA class II α and β chains form receptors for antigen presentation to CD4(+) T cells. Numerous pairings of class II α and β subunits from the wide range of haplotypes and isotypes may form, but most of these combinations, in particular those produced by isotype mixing, yielded mismatched dimers. It is unclear how selection of functional receptors is achieved. At the atomic level, it is not known which interactions of class II residues regulate selection of matched αβ heterodimers and the evolutionary origin of matched isotype mixed dimer formation. In this study we investigated assembly of isotype-mixed HLA class II α and β heterodimers. Assembly and carbohydrate maturation of various HLA-class II isotype-mixed α and β subunits was dependent on the groove binding section of the invariant chain (Ii). By mutation of polymorphic DPβ sequences, we identified two motifs, Lys-69 and GGPM-(84-87), that are engaged in Ii-dependent assembly of DPβ with DRα. We identified five members of a family of DPβ chains containing Lys-69 and GGPM 84-87, which assemble with DRα. The Lys/GGPM motif is present in the DPβ sequence of the Neanderthal genome, and this ancient sequence is related to the human allele DPB1*0401. By site-directed mutagenesis, we inspected Neanderthal amino acid residues that differ from the DPB1*0401 allele and aimed to determine whether matched heterodimers are formed by assembly of DPβ mutants with DRα. Because the *0401 allele is rare in the sub-Saharan population but frequent in the European population, it may have arisen in modern humans by admixture with Neanderthals in Europe.

Indexed as

Evolution, MolecularImmunoblottingMutationAmino Acid SequenceAnimalsAntigens, Differentiation, B-LymphocyteBinding SitesCell LineChlorocebus aethiopsCOS CellsHistocompatibility Antigens Class IIHLA-DP alpha-ChainsHLA-DP AntigensHLA-DP beta-ChainsHLA-DR alpha-ChainsHLA-DR AntigensAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIHLA-DP alpha-ChainsHLA-DP AntigensHLA-DPB1*04:01 antigenHLA-DP beta-ChainsHLA-DR alpha-ChainsHLA-DR AntigensHLA-DR beta-Chainsinvariant chainAntigen PresentationHLA Class IIInvariant ChainMajor Histocompatibility Complex (MHC)Protein AssemblyProtein DomainsProtein Evolution

Identifiers

PMID24214983
PMCPMC3887193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.